[Anesthesia used in minimally invasive myocardial revascularization surgery].
As myocardial revascularisation operations without cardiopulmonary bypass are getting more popular, more facts are found about their surgical techniques. However, the questions considering their anesthesia, the protection of myocardium and other are not widely analyzed. The specific features of anesthesia in cardiosurgery, such as methods of ventilation, combination of induction and general anesthesia with epidural anesthesia, usage of cardiac protection and ischemic preconditioning, monitoring, heparin management, usage of drugs, postoperative pain management are given in this article. As anesthesiological and surgical techniques are getting better and the professional skills of surgeons and anesthesiologists are improving, given data should improve the perspectives of minimally invasive cardio surgery operations and anesthesia in Lithuania.
Jakutis
Virginijus
V
Kauno medicinos universiteto Biomedicininiu tyrimu institutas, Eiveniu 4, 3007 Kaunas.
Giedraitis
Saulius
S
Sirvinskas
Edmundas
E
Dumcius
Marius
M
D000368:Aged; D000767:Anesthesia, Epidural; D000768:Anesthesia, General; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D002315:Cardiopulmonary Bypass; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007902:Length of Stay; D019060:Minimally Invasive Surgical Procedures; D008991:Monitoring, Physiologic; D009204:Myocardial Revascularization; D010149:Postoperative Pain / Q000517:prevention & control; D011229:Preanesthetic Medication; D012121:Respiration, Artificial; D012307:Risk Factors
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006493:Heparin